Due to export licence requirements, we are henceforth unable to fulfil orders for medications containing codeine that require delivery to addresses outside the UK. This includes codeine phosphate, co-codamol, Kapake, Solpadol, and Co-Dydramol.
Orders dispatched to UK addresses are NOT affected by this and will be fulfilled in the usual way.
We apologise for any inconvenience.
On August 28th, changes were made to our merchant’s security gateway to augment security. One of the consequences of this change is that all future transactions have to be billed in Euros. Express MD prices were always based in Euros anyway with GBP prices provided as a convenience, so this will have no effect on the price of medications. Patients will also continue to be able to use GBP denominated credit or debit cards, but the transactions will be billed in Euros.
If you have any questions or concerns related to this, please call customer services on +44 203 239 8452.
Commonly used sleeping tablets including Valium are reported to be linked to an increased risk of dementia, according to a recently published study Harvard Medical School. Seniors taking these pills – called benzodiazapines – may be running a 50% greater chance of succumbing to this scourge of aging. This group of medicines includes temazepam and diazepam (Valium) which are widely prescribed for anxiety and sleeping difficulties which result from this condition. In the UK 10 million prescriptions a year are issued for these medications and among the over 65s, up 8% or so have used within the past year.
These medication work by interfering with chemicals in the brain known as neurotransmitters and there has long been concern that there is a potential that they were harmful. The risk of addiction when taking benzodiazapines has long been documented and for this reason doctors in the UK have reduced the number of prescriptions issued over the past 20 years. Earlier studies have indicated that they increase the risk of early death too with those taking 4 to 18 pills a year 3.6 times more likely to die prematurely.
There are 800,000 people in the UK with dementia and the cost of treating this condition is estimate by the NHS to be £35 billion.
Should all over 50s be taking statins?
the debate was reignited by Professor Collins at the European Cardiology Congress in Munich. He reported that evidence from 130,000 patients taking statins in trials show they are safe and consequently they should be given to all over-50s whether they have heart disease or not.
Yet is view is not endorsed by drug safety watchdogs here who have insisted on flagging up relatively minor side effects which are putting patients off the drugs. These include memory loss, depression, sexual difficulties and depression. According to Prof Collins, trial data shows only one significant side effect, myopathy or muscle pain, which affects one in 10,000 patients. Read more…